Atomoxetine Hydrochloride Patent Expiration

Atomoxetine Hydrochloride is Used for managing symptoms of attention-deficit hyperactivity disorder. It was first introduced by Eli Lilly And Co in its drug Strattera on Nov 26, 2002. 9 different companies have introduced drugs containing Atomoxetine Hydrochloride.


Atomoxetine Hydrochloride Patents

Given below is the list of patents protecting Atomoxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Strattera US5658590

(Pediatric)

Treatment of attention-deficit/hyperactivity disorder May 26, 2017

(Expired)

Lilly
Strattera US5658590 Treatment of attention-deficit/hyperactivity disorder Nov 26, 2016

(Expired)

Lilly



Atomoxetine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Atomoxetine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Atomoxetine Hydrochloride. The first generic version for Atomoxetine Hydrochloride was by Zydus Pharmaceuticals Usa Inc and was approved on Sep 16, 2010. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Apr 5, 2023.

Given below is the list of companies who have filed for Atomoxetine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. APOTEX

Apotex Inc has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 18MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 25MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 40MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 60MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 80MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 100MG BASE

capsule Prescription ORAL AB May 30, 2017


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
North York Apotex Inc.
Winnipeg Apotex Fermentation Inc.
Etobicoke Apotex, Inc.
Brantford Apotex Pharmachem Inc.
India
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.
Bengaluru Apotex Research Private Limited





2. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 18MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 10MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 25MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 40MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 60MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 80MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 100MG BASE

capsule Prescription ORAL AB May 30, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Sangareddy Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
United States
East Windsor Aurobindo Pharma USA Inc





3. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Feb 23, 2018
EQ 100MG BASE

capsule Prescription ORAL AB Feb 23, 2018
EQ 80MG BASE

capsule Prescription ORAL AB Feb 23, 2018
EQ 60MG BASE

capsule Prescription ORAL AB Feb 23, 2018
EQ 40MG BASE

capsule Prescription ORAL AB Feb 23, 2018
EQ 25MG BASE

capsule Prescription ORAL AB Feb 23, 2018
EQ 18MG BASE

capsule Prescription ORAL AB Feb 23, 2018





4. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 18MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 25MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 40MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 60MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 80MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 100MG BASE

capsule Prescription ORAL AB May 30, 2017





5. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

capsule Prescription ORAL AB Mar 11, 2021
EQ 10MG BASE

capsule Prescription ORAL AB Mar 11, 2021
EQ 18MG BASE

capsule Prescription ORAL AB Mar 11, 2021
EQ 100MG BASE

capsule Prescription ORAL AB Mar 11, 2021
EQ 80MG BASE

capsule Prescription ORAL AB Mar 11, 2021
EQ 60MG BASE

capsule Prescription ORAL AB Mar 11, 2021
EQ 40MG BASE

capsule Prescription ORAL AB Mar 11, 2021





6. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 80MG BASE

capsule Prescription ORAL AB Feb 18, 2021
EQ 10MG BASE

capsule Prescription ORAL AB Feb 18, 2021
EQ 18MG BASE

capsule Prescription ORAL AB Feb 18, 2021
EQ 25MG BASE

capsule Prescription ORAL AB Feb 18, 2021
EQ 40MG BASE

capsule Prescription ORAL AB Feb 18, 2021
EQ 60MG BASE

capsule Prescription ORAL AB Feb 18, 2021
EQ 100MG BASE

capsule Prescription ORAL AB Feb 18, 2021


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Puducherry Strides Pharma Science Limited
Bangalore Strides Pharma Science Limited





7. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 18MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 25MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 40MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 60MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 80MG BASE

capsule Prescription ORAL AB May 30, 2017
EQ 100MG BASE

capsule Prescription ORAL AB May 30, 2017





8. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Atomoxetine Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 18MG BASE

capsule Prescription ORAL AB Sep 16, 2010
EQ 25MG BASE

capsule Prescription ORAL AB Sep 16, 2010
EQ 40MG BASE

capsule Prescription ORAL AB Sep 16, 2010
EQ 60MG BASE

capsule Prescription ORAL AB Sep 16, 2010
EQ 80MG BASE

capsule Prescription ORAL AB Sep 16, 2010
EQ 100MG BASE

capsule Prescription ORAL AB Sep 16, 2010
EQ 10MG BASE

capsule Prescription ORAL AB Apr 5, 2023